Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: ALS


ABC News story on new ALS drug Radicava included many caveats–except the most important one


CNN can’t resist lure of early-phase ALS stem cell research, but keeps tone moderate


U-M oversees cutting-edge trial that offers hope in fight against Lou Gehrig’s disease